MBX
#1726
MBX Biosciences, Inc. - Common Stock
61.6 0 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.22%
Variación mensual
-6.65%
Variación en los últimos 6 meses
+97.69%
Cambio anual
+312.32%
Cierres anteriores
63.0 0
Open
61.6 0
Mínimo
61.6 0
Máximo
61.6 0
Volumen
89
Financials
- Market Capitalization 2.97 B
- Employee 63
- Founded 2018
- CEO N/A
- Website www.mbxbio.com
- Headquarter Delaware, United States
- FIGI BBG00W7W53M5
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1492 |  MANE Veradermics, Incorporated Common Stock | 98.24 USD | +0.41% | -1.06% | -3.83% | +197.70% | 4.10 B USD | ||
| 1576 |  OGN Organon & Co. Common Stock | 13.76 USD | -0.07% | +0.07% | +1.47% | +89.53% | 3.61 B USD | ||
| 1900 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 48.67 USD | -0.21% | -2.46% | +19.20% | +85.83% | 2.34 B USD | ||
| 1936 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 152.59 USD | +1.75% | +2.69% | +10.52% | +106.62% | 2.20 B USD |